Daiwa Securities Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
439
| – | – | ﹤0.01% | 1144 |
|
|
2025
Q1 | $7K | Hold |
439
| – | – | ﹤0.01% | 1110 |
|
|
2024
Q4 | $6K | Hold |
439
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q3 | $4K | Hold |
439
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q2 | $4K | Buy |
439
+194
| +79% | +$1.77K | ﹤0.01% | 1198 |
|
|
2024
Q1 | $2K | Hold |
245
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q4 | $1K | Hold |
245
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q3 | $1K | Hold |
245
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q2 | $2K | Hold |
245
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q1 | $3K | Hold |
245
| – | – | ﹤0.01% | 1167 |
|
|
2022
Q4 | $4K | Buy |
245
+73
| +42% | +$1.19K | ﹤0.01% | 1157 |
|
|
2022
Q3 | $3K | Hold |
172
| – | – | ﹤0.01% | 1181 |
|
|
2022
Q2 | $4K | Hold |
172
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q1 | $3K | Hold |
172
| – | – | ﹤0.01% | 1202 |
|
|
2021
Q4 | $4K | Hold |
172
| – | – | ﹤0.01% | 1204 |
|
|
2021
Q3 | $4K | Buy |
172
+73
| +74% | +$1.7K | ﹤0.01% | 1183 |
|
|
2021
Q2 | $3K | Hold |
99
| – | – | ﹤0.01% | 1099 |
|
|
2021
Q1 | $3K | Buy |
99
+17
| +21% | +$515 | ﹤0.01% | 1097 |
|
|
2020
Q4 | $2K | Buy |
+82
| New | +$2K | ﹤0.01% | 1109 |
|